BioPharma Credit PLC
BOPCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $6 | $37 | $135 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $54 | $32 | $37 | $20 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $59 | $37 | $74 | $155 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1,099 | $1,162 | $1,157 | $1,201 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,099 | $1,162 | $1,157 | $1,201 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,158 | $1,200 | $1,232 | $1,357 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $17 | $3 | $16 |
| Total Curr. Liab. | $7 | $18 | $3 | $16 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $18 | $4 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $14 | $14 | $14 | $14 |
| Retained Earnings | $529 | $561 | $607 | $720 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $607 | $607 | $607 | $607 |
| Total Equity | $1,150 | $1,182 | $1,228 | $1,341 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,158 | $1,200 | $1,232 | $1,357 |
| Net Debt | -$4 | -$6 | -$37 | -$135 |